Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization
1984571 citationsP. E. Miller, HC Hemmings et al.Journal of Neuroscienceprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of P. E. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. E. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. E. Miller more than expected).
This network shows the impact of papers produced by P. E. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. E. Miller. The network helps show where P. E. Miller may publish in the future.
Co-authorship network of co-authors of P. E. Miller
This figure shows the co-authorship network connecting the top 25 collaborators of P. E. Miller.
A scholar is included among the top collaborators of P. E. Miller based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with P. E. Miller. P. E. Miller is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
12 of 12 papers shown
1.
Yao, Zhenling, et al.. (2009). Prevention of Laser Photocoagulation Induced Choroidal Neovascularization Lesions by Intravitreal Doses of Ranibizumab in Cynomolgus Monkeys. Investigative Ophthalmology & Visual Science. 50(13). 785–785.2 indexed citations
2.
Miller, P. E., Henry F. Edelhauser, C. J. Murphy, et al.. (2008). Corneal Endothelial Cell Density Measurements Using Noncontact Specular Microscopy in Rabbits, Dogs and Monkeys. Investigative Ophthalmology & Visual Science. 49(13). 2819–2819.1 indexed citations
3.
Forrest, Lisa J., Jessica Lawrence, P. E. Miller, et al.. (2006). 2387. International Journal of Radiation Oncology*Biology*Physics. 66(3). S425–S425.5 indexed citations
4.
Miller, P. E., Michelle Turek, Lisa J. Forrest, et al.. (2005). Ocular Sparing Using Intensity Modulated Radiation Therapy (IMRT) in a Canine Model of Spontaneous Sinonasal Cancer: Proof–of–Principle of Conformal Avoidance. Investigative Ophthalmology & Visual Science. 46(13). 5408–5408.1 indexed citations
5.
Miller, P. E., et al.. (2002). The Effect of 0.005% Latanoprost on the Canine Iridocorneal Angle: An Ultrasound Biomicroscopic Study. Investigative Ophthalmology & Visual Science. 43(13). 4073–4073.1 indexed citations
6.
Miller, P. E. & Christopher J. Murphy. (1995). Vision in dogs.. PubMed. 207(12). 1623–34.134 indexed citations
7.
Miller, P. E., et al.. (1994). Canine keratomycosis: A report of eight cases and literature review. Journal of the American Animal Hospital Association. 30(4). 331–340.17 indexed citations
8.
Miller, P. E., et al.. (1990). Feline blastomycosis: a report of three cases and literature review (1961 to 1988).. Journal of the American Animal Hospital Association. 26(4). 417–424.20 indexed citations
Miller, P. E., et al.. (1984). DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. Journal of Neuroscience. 4(1). 111–124.571 indexed citations breakdown →
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.